GLUE Deferred Revenue
Monte Rosa Therapeutics Inc · Deferred Revenue
GLUE Deferred Revenue
Latest reported$29.57Mperiod ending
GLUE FY Deferred Revenue ($0.00 → $29.57M)
Annual deferred revenue
High-resolution chart · PNG
GLUE deferred revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 29,571,000 | |
| 117,232,000 | |
| 17,678,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |